Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time.

Parikh, S; Wilding, J; Jabbour, S; Hardy, E

Parikh, S; Wilding, J; Jabbour, S; Hardy, E.

Affiliation

Parikh S; AstraZeneca, Gaithersburg, MD, USA.

Int J Clin Pract ; 69(2): 186-98, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25438821

Subject(s)

Benzhydryl Compounds/therapeutic use; Diabetes Mellitus, Type 2/drug therapy; Glucosides/therapeutic use; Glycated Hemoglobin/drug effects; Treatment Outcome; Adult; Aged; Blood Glucose/drug effects; Body Weight/drug effects; Double-Blind Method; Female; Humans; Hypoglycemic Agents/administration & dosage; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Male; Middle Aged; Urinary Tract Infections/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzhydryl Compounds / Glycated Hemoglobin / Treatment Outcome / Diabetes Mellitus, Type 2 / Glucosides Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2015 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google